Westlake Chemical Partners LP - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Westlake Chemical Partners LP on September 28, 2017, reporting an event that occurred on September 26, 2017. The filing details a public equity offering and a related acquisition strategy.
Key Financial Metrics and Transaction Details
- Equity Offering: Sale of 4,500,000 common units at $22.00 per unit.
- Net Proceeds: Approximately $96.5 million (after underwriting discounts and commissions).
- Underwriting Option: Underwriters granted a 30-day option to purchase up to an additional 675,000 common units.
- Debt Financing: The Partnership plans to borrow approximately $133.1 million under its revolving credit facility.
- Total Capital Raised: Combined equity and debt proceeds total approximately $229.6 million.
Material Changes and Use of Proceeds
The primary material change is the execution of an underwriting agreement with UBS Securities LLC and Citigroup Global Markets Inc. The net proceeds from the equity offering, combined with the new debt borrowing, will be used to fund the acquisition of additional interests in the Partnership's partially owned subsidiary, Westlake Chemical OpCo LP. The transaction was expected to close on September 29, 2017.
Outlook, Risks, and Contingencies
The filing notes that the Underwriting Agreement contains customary representations, warranties, and indemnification provisions. Affiliates of the underwriters have provided and may continue to provide commercial banking, investment banking, and advisory services to the Partnership. The filing does not provide specific forward-looking guidance on future revenue or earnings, nor does it detail specific risks beyond standard underwriting contingencies.
Key Facts for Investor Verification
- Verify the closing of the offering on or around September 29, 2017.
- Confirm the exercise of the 30-day underwriter option for the additional 675,000 units.
- Monitor the completion of the acquisition of additional interests in Westlake Chemical OpCo LP.
- Review the impact of the $133.1 million increase in debt on the Partnership's leverage ratios.